Compendial Dissolution Testing
Compendial Dissolution Testing is a standardized pharmaceutical analytical procedure, belonging to the class of in vitro drug release assessment methods, that specifically quantifies the rate and extent of active ingredient release from a dosage form under prescribed conditions outlined in official compendia such as the USP, Ph. Eur., or JP.
21
Publications
694
Citations
102
Authors
40
Institutions
Publications per year
2017–2026
6
Parents
21
Milica Drašković, Djordje Medarević, Ivana Aleksić et al. · Drug Development and Industrial Pharmacy · 2016 · 49 citations · Full text
1–5 of 21
102
National and Kapodistrian University of Athens, Greece
2 publications · 78 citations
2
h-index
2
h-index
2
h-index
2
h-index
2
h-index
1–5 of 102
40

University of Rostock
Rostock, Germany
1 h-index
2 publications
26 citations
Åbo Akademi University
Turku, Finland
1 h-index
1 publications
46 citations
Therapeutics Systems Research Laboratories (United States)
Ann Arbor, United States
1 h-index
1 publications
23 citations
Amgen (United States)
Thousand Oaks, United States
1 h-index
5 publications
245 citations

University of Bath
Bath, United Kingdom
1 h-index
1 publications
68 citations
Beltsville Human Nutrition Research Center
Beltsville, United States
1 h-index
7 publications
140 citations

University of Nottingham
Nottingham, United Kingdom
1 h-index
7 publications
133 citations
National Institute of Health Sciences
Tokyo, Japan
1 h-index
1 publications
56 citations
1–8 of 40
5 publications · 143 citations
5
h-index
3 publications · 94 citations
3
h-index
3 publications · 76 citations
3
h-index
2 publications · 76 citations
2
h-index
1 publications · 49 citations
1
h-index
1–5